Project Grant R01DE034025
Award Date
7/1/25
Completion Date
3/31/30
Dollars Obligated
$534K
Federal Agency
National Institute of Dental and Craniofacial Research
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
New Hampshire, USA
Similar Awards
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), totals $499,105 and will support research to develop novel microRNA-based therapeutics to enhance bone regeneration and suppress tumor growth in oral cancer patients undergoing radiation therapy. The key goals are to determine the functions of microRNA-200c in promoting mandibular bone regeneration under radiation conditions and...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $714,711 to the Icahn School of Medicine at Mount Sinai to study mechanisms for protecting and regenerating salivary glands after radiation therapy. The key focus is on identifying genetic targets, such as SMARCA2 depletion, that can specifically promote salivary epithelium growth without also benefiting cancer growth....
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a Project Grant (CFDA 93.121 - Oral Diseases and Disorders Research) totaling $690,625 to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The grant, awarded on August 12, 2024, will support research to explore whether the FDA-approved iron oxide nanoparticle formulation ferumoxytol can activate orofacial mesenchymal stem/progenitor cells (OMSCs) and...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will provide $429,000.00 to the Regents of the University of Michigan to conduct research on the unique characteristics of jawbone biology. The research aims to gain a molecular-level understanding of how osteoblasts in the jawbone respond differently to bone morphogenetic protein (BMP) signaling and mechanical loading...
This Project Grant award of $3,069,994.00 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121), supports a multi-faceted research program focused on elucidating the role of skeletal stem cell plasticity in craniofacial bone diseases. The primary awardee, the University of Texas Health Science Center at Houston, will investigate the fates and functions of periosteal and endosteal stem cells in...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $1,654,218 Project Grant (CFDA 93.121 - Oral Diseases and Disorders Research) to Emory University to develop an artificial intelligence-driven system for online adaptive and personalized proton therapy (AID-ON-APPT). The proposed system will leverage deep learning and reinforcement learning to enable real-time adaptive radiation therapy for head and neck cancer patients, improving tumor coverage while reducing dose to...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $1,352,406.84 Project Grant (Grant ID: R01DE033175) to Trustees of Dartmouth College under the Oral Diseases and Disorders Research program (CFDA 93.121). The goal of this 4-year project is to develop a noninvasive ultrasound-based molecular imaging tool to identify micrometastases in the lymphatics of head and neck cancer patients. The project involves creating perfluorocarbon nanodroplet contrast agents targeted to...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $606,296 project grant (CFDA 93.121 - Oral Diseases and Disorders Research) to the University of Missouri System on May 1, 2025. The grant supports a 5-year research project to develop state-of-the-art, three-dimensional growth models of the craniofacial complex using advanced cone-beam computed tomography (CBCT) imaging. The goal is to create new growth standards that incorporate the three-dimensional nature of the...
This federal Project Grant award, valued at $294,000 and spanning September 2024 to September 2026, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) program. The grant supports research to understand the mechanisms of craniofacial cartilage differentiation from human neural crest stem cells, with the goal of developing tissue engineering approaches to repair birth defects and injuries to the head and...
The National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), awarded a $613,736 Project Grant to Cayman Chemical Co Inc. to develop novel osteogenic small-molecule pharmacotherapies for local delivery that stimulate alveolar bone regeneration. The goal is to address the clinical need for improved treatments for periodontitis-related bone resorption, especially in aging populations. The project leverages Cayman...